Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

Similar articles for PubMed (Select 22878500)

1.

Loss of the tumor suppressor BAP1 causes myeloid transformation.

Dey A, Seshasayee D, Noubade R, French DM, Liu J, Chaurushiya MS, Kirkpatrick DS, Pham VC, Lill JR, Bakalarski CE, Wu J, Phu L, Katavolos P, LaFave LM, Abdel-Wahab O, Modrusan Z, Seshagiri S, Dong K, Lin Z, Balazs M, Suriben R, Newton K, Hymowitz S, Garcia-Manero G, Martin F, Levine RL, Dixit VM.

Science. 2012 Sep 21;337(6101):1541-6. Epub 2012 Aug 9.

2.

The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression.

Yu H, Mashtalir N, Daou S, Hammond-Martel I, Ross J, Sui G, Hart GW, Rauscher FJ 3rd, Drobetsky E, Milot E, Shi Y, Affar el B.

Mol Cell Biol. 2010 Nov;30(21):5071-85. doi: 10.1128/MCB.00396-10. Epub 2010 Aug 30.

3.

Cancer. Emerging anatomy of the BAP1 tumor suppressor system.

White AE, Harper JW.

Science. 2012 Sep 21;337(6101):1463-4. No abstract available.

PMID:
22997315
4.

The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics.

Abdel-Wahab O, Dey A.

Leukemia. 2013 Jan;27(1):10-5. doi: 10.1038/leu.2012.288. Epub 2012 Oct 9. Review.

PMID:
23147254
5.

BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma.

Matatall KA, Agapova OA, Onken MD, Worley LA, Bowcock AM, Harbour JW.

BMC Cancer. 2013 Aug 5;13:371. doi: 10.1186/1471-2407-13-371.

6.

Retracted: Histone H2B ubquitination regulates retinoic acid signaling through the cooperation of ASXL1 and BAP1.

Lee SW, Youn H, Kim EJ, Um SJ.

Mol Cell. 2013 Jul 25;51(2):200-10. doi: 10.1016/j.molcel.2013.06.005. Epub 2013 Jul 11. Retraction in: Mol Cell. 2013 Aug 22;51(4):552.

7.

An emerging model for BAP1's role in regulating cell cycle progression.

Eletr ZM, Wilkinson KD.

Cell Biochem Biophys. 2011 Jun;60(1-2):3-11. doi: 10.1007/s12013-011-9184-6. Review.

8.

The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.

Machida YJ, Machida Y, Vashisht AA, Wohlschlegel JA, Dutta A.

J Biol Chem. 2009 Dec 4;284(49):34179-88. doi: 10.1074/jbc.M109.046755. Epub 2009 Oct 8.

9.

Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo.

Abdel-Wahab O, Gao J, Adli M, Dey A, Trimarchi T, Chung YR, Kuscu C, Hricik T, Ndiaye-Lobry D, Lafave LM, Koche R, Shih AH, Guryanova OA, Kim E, Li S, Pandey S, Shin JY, Telis L, Liu J, Bhatt PK, Monette S, Zhao X, Mason CE, Park CY, Bernstein BE, Aifantis I, Levine RL.

J Exp Med. 2013 Nov 18;210(12):2641-59. doi: 10.1084/jem.20131141. Epub 2013 Nov 11.

10.

[Role of ASXL1 mutation in myeloid malignancies].

Sheng MY, Zhou Y, Xu MJ, Yang FC.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Aug;22(4):1183-7. doi: 10.7534/j.issn.1009-2137.2014.04.057. Review. Chinese.

PMID:
25130853
11.

Tumours associated with BAP1 mutations.

Murali R, Wiesner T, Scolyer RA.

Pathology. 2013 Feb;45(2):116-26. doi: 10.1097/PAT.0b013e32835d0efb. Review.

PMID:
23277170
12.

BAP1 loss defines a new class of renal cell carcinoma.

Peña-Llopis S, Vega-Rubín-de-Celis S, Liao A, Leng N, Pavía-Jiménez A, Wang S, Yamasaki T, Zhrebker L, Sivanand S, Spence P, Kinch L, Hambuch T, Jain S, Lotan Y, Margulis V, Sagalowsky AI, Summerour PB, Kabbani W, Wong SW, Grishin N, Laurent M, Xie XJ, Haudenschild CD, Ross MT, Bentley DR, Kapur P, Brugarolas J.

Nat Genet. 2012 Jun 10;44(7):751-9. doi: 10.1038/ng.2323. Erratum in: Nat Genet. 2012 Sep;44(9):1072.

13.

Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.

Gelsi-Boyer V, Trouplin V, Adélaïde J, Bonansea J, Cervera N, Carbuccia N, Lagarde A, Prebet T, Nezri M, Sainty D, Olschwang S, Xerri L, Chaffanet M, Mozziconacci MJ, Vey N, Birnbaum D.

Br J Haematol. 2009 Jun;145(6):788-800. doi: 10.1111/j.1365-2141.2009.07697.x. Epub 2009 Apr 15.

PMID:
19388938
14.

ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.

Abdel-Wahab O, Adli M, LaFave LM, Gao J, Hricik T, Shih AH, Pandey S, Patel JP, Chung YR, Koche R, Perna F, Zhao X, Taylor JE, Park CY, Carroll M, Melnick A, Nimer SD, Jaffe JD, Aifantis I, Bernstein BE, Levine RL.

Cancer Cell. 2012 Aug 14;22(2):180-93. doi: 10.1016/j.ccr.2012.06.032.

15.

Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse.

Sportoletti P, Grisendi S, Majid SM, Cheng K, Clohessy JG, Viale A, Teruya-Feldstein J, Pandolfi PP.

Blood. 2008 Apr 1;111(7):3859-62. doi: 10.1182/blood-2007-06-098251. Epub 2008 Jan 22.

16.

Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice.

Wang J, Li Z, He Y, Pan F, Chen S, Rhodes S, Nguyen L, Yuan J, Jiang L, Yang X, Weeks O, Liu Z, Zhou J, Ni H, Cai CL, Xu M, Yang FC.

Blood. 2014 Jan 23;123(4):541-53. doi: 10.1182/blood-2013-05-500272. Epub 2013 Nov 19.

17.

Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1.

Misaghi S, Ottosen S, Izrael-Tomasevic A, Arnott D, Lamkanfi M, Lee J, Liu J, O'Rourke K, Dixit VM, Wilson AC.

Mol Cell Biol. 2009 Apr;29(8):2181-92. doi: 10.1128/MCB.01517-08. Epub 2009 Feb 2.

18.

Germline BAP1 mutations predispose to malignant mesothelioma.

Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, Tanji M, Gaudino G, Yang H, Carbone M.

Nat Genet. 2011 Aug 28;43(10):1022-5. doi: 10.1038/ng.912.

19.

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.

Abdel-Rahman MH, Pilarski R, Cebulla CM, Massengill JB, Christopher BN, Boru G, Hovland P, Davidorf FH.

J Med Genet. 2011 Dec;48(12):856-9. doi: 10.1136/jmedgenet-2011-100156. Epub 2011 Sep 22.

20.

The THAP-zinc finger protein THAP1 associates with coactivator HCF-1 and O-GlcNAc transferase: a link between DYT6 and DYT3 dystonias.

Mazars R, Gonzalez-de-Peredo A, Cayrol C, Lavigne AC, Vogel JL, Ortega N, Lacroix C, Gautier V, Huet G, Ray A, Monsarrat B, Kristie TM, Girard JP.

J Biol Chem. 2010 Apr 30;285(18):13364-71. doi: 10.1074/jbc.M109.072579. Epub 2010 Mar 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk